BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35727816)

  • 1. Patient-reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort study.
    Belhomme N; Morcet J; Lescoat A; Robin F; Deugnier Y; Bardou-Jacquet E; Lainé F
    Liver Int; 2022 Nov; 42(11):2473-2481. PubMed ID: 35727816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
    Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
    Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
    Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of 5 patients with possible primary hemochromatosis].
    Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worse Outcomes of Patients With HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy.
    Bardou-Jacquet E; Lainé F; Guggenbuhl P; Morcet J; Jézéquel C; Guyader D; Moirand R; Deugnier Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1620-1627. PubMed ID: 28111337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis.
    Carter K; Bowen DJ; McCune CA; Worwood M
    Br J Haematol; 2003 Jul; 122(2):326-32. PubMed ID: 12846904
    [TBL] [Abstract][Full Text] [Related]  

  • 8.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary haemochromatosis in two cousins with cluster headache.
    Stovner LJ; Hagen K; Waage A; Bjerve KS
    Cephalalgia; 2002 May; 22(4):317-9. PubMed ID: 12100096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients.
    McCune CA; Ravine D; Carter K; Jackson HA; Hutton D; Hedderich J; Krawczak M; Worwood M
    Gut; 2006 Apr; 55(4):554-62. PubMed ID: 16174659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
    Barton JC; Barton EH; Acton RT
    BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.
    Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A
    Blood Cells Mol Dis; 2022 Nov; 97():102689. PubMed ID: 35780678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis.
    Cadet E; Capron D; Perez AS; Crépin SN; Arlot S; Ducroix JP; Dautréaux M; Fardellone P; Leflon P; Merryweather-Clarke AT; Livesey KJ; Pointon JJ; Rose P; Harcourt J; Emery J; Sueur JM; Feyt R; Robson KJ; Rochette J
    J Intern Med; 2003 Feb; 253(2):217-24. PubMed ID: 12542563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EASL Clinical Practice Guidelines on haemochromatosis.
    ;
    J Hepatol; 2022 Aug; 77(2):479-502. PubMed ID: 35662478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Study of HFE Genotypes and Its Expression Effect on Iron Status of Iranian Haemochromatosis, Iron Deficiency Anemia Patients, Iron-Taker and Non Iron-Taker Controls.
    Beiranvand E; Abediankenari S; Rostamian M; Beiranvand B; Naazeri S
    Recent Adv DNA Gene Seq; 2015; 9(1):58-64. PubMed ID: 25687342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemochromatosis.
    Adams PC; Barton JC
    Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.